Stat3 and Gfi-1 Transcription Factors Control Th17 Cell Immunosuppressive Activity via the Regulation of Ectonucleotidase Expression
Fanny Chalmin(Inserm), François Ghiringhelli(Inserm), Jean‐René Pallandre(Inserm), Cédric Rébé(Inserm), Simon C. Robson(Beth Israel Deaconess Medical Center), Frédérique Végran(Inserm), Angélique Chevriaux(Inserm), Sylvain Ladoire(Inserm), Grégoire Mignot(Inserm), Valentin Dérangère(Inserm), David Masson(Inserm), Lionel Apétoh(Indiana University Health), Aziz Hichami(Inserm), Mélanie Bruchard(Inserm), Christophe Borg(Inserm), Gérard Eberl(Inserm), Julie Vincent(Inserm), Bernhard Ryffel(Immunologie et Neurogénétique Expérimentales et Moléculaires)
Cited by 324
Related Papers
Gut microbiome influences efficacy of PD-1–based immunotherapy against epithelial tumors
|Science|2017|5.4k
Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression
|The Journal of Experimental Medicine|2007|2.4k
Negative feedback control of neuronal activity by microglia
|Nature|2020|997
Membrane-associated Hsp72 from tumor-derived exosomes mediates STAT3-dependent immunosuppressive function of mouse and human myeloid-derived suppressor cells
|Journal of Clinical Investigation|2010|985
The E-NTPDase family of ectonucleotidases: Structure function relationships and pathophysiological significance
|Purinergic Signalling|2006|928